Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections

Abroad (travel likely)RecruitingPHASE4

Conditions

Gonorrhea · Chlamydia · Syphilis · Sexually Transmitted Infections (STIs)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • UCLA Care, Los Angeles, California, United States

    Contact: Study coordinator (Emy Arango) · earango@mednet.ucla.edu · 310-825-6413
    Contact: Principal Investigator (Cherie Blaire)
  • San Francisco Department of Public Health, San Francisco, California, United States

    Contact: Study coordinator (Emily Schaeffer) · emily.schaeffer@sfdph.org · 628-217-7456
    Contact: Principal Investigator (Albert Liu)
  • Children's National Medical Center, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Justin Unternaher) · junternahe@childrensnational.org · 202-476-1030
    Contact: Principal Investigator (Natella Rakhmanina)
  • University of Florida, Tampa, Florida, United States

    Contact: Study coordinator (Elizabeth Enriquez-Bruce) · enriquezbruce@usf.edu · 813-250-2574
    Contact: Principal Investigator (Patricia Emmanuel)
  • Ponce de Leon, Atlanta, Georgia, United States

    Contact: Study coordinator (Christin Root) · cmroot@emory.edu · 404-251-8893
    Contact: Principal Investigator (Anandi Sheth)
  • University Illinois Chicago, Chicago, Illinois, United States

    Contact: Study coordinator (Rachel Jackson) · rjacks34@uic.edu · 312-996-6018
    Contact: Principal Investigator (Kelly Bojan)
  • Tulane University, New Orleans, Louisiana, United States

    Contact: Study coordinator (Leslie Kozina) · lkozina@tulane.edu · 504-988-5348
    Contact: Principal Investigator (Tina Simpson)
  • Johns Hopkins University, Baltimore, Maryland, United States

    Contact: Study coordinator (Jessica Coleman) · jcolem52@jh.edu · 3013854868
    Contact: Principal Investigator (Allison Agwu, MD)
  • Harlem Prevention Center, New York, New York, United States

    Contact: Study coordinator (Yan Rivera) · yr2267@cumc.columbia.edu · 917-846-9907
    Contact: Principal Investigator (Yael Hirsch-Movermann)
  • Chapel Hill, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Mariam Chicurel-Bayard) · chicurel@med.unc.edu · 919-843-9922
    Contact: Principal Investigator (Lina Rosengren-Hovee)
  • Penn Prevention, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Rosemarie Kappes) · rkappes@pennmedicine.upenn.edu · 267-229-2972
    Contact: Principal Investigator (Arianne Morrison)
  • St. Jude Children's Research Hospital, Memphis, Tennessee, United States

    Contact: Study coordinator (Mary Dillard) · Mary.dillard@stjude.org · 901-595-4083
    Contact: Principal Investigator (Aditya Gaur)
  • Baylor College of Medicine, Houston, Texas, United States

    Contact: Study coordinator (Litty Koshy) · Litty.Koshy@bcm.edu · 832-822-1038
    Contact: Principal Investigator (Mary Paul)
Study leads
  • Cherie Blaire, MD, PhD

    Study Chair

    University of California, Los Angeles

  • Jenell Stewart, DO, MPH

    Study Chair

    Hennepin Healthcare